Abstract 1851P
Background
We have previously reported on the initial results of the prospective longitudinal PICO-SM study (Lim et al. 2023), highlighting the impact of the COVID-19 pandemic on the lives of patients with colorectal cancer. Herein, we present the psychological impact of the third wave of the pandemic to patients, when the Omicron variant became prevalent (December 2021 to early 2022).
Methods
Patients were invited to participate in cohort II of the PICO-SM study by completing a questionnaire, including screening psychometric tools. Multivariate analysis was performed using logistic regression for binary outcomes: anxiety (GAD-7 score ≥ 5), depression (PHQ-9 score ≥ 10), and poor well-being (WHO-5 < 50); and odds ratios (OR) with 95% confidence interval (CI) were calculated.
Results
In total, 96 participants were included: mean age 64 years, 64% (n = 61) males. 33% (n = 32/96) reported poor well-being (WHO-5 < 50), 27% (n = 26/96) anxiety (GAD-7 ≥ 5), 11% (n = 11/96) depressive symptoms (PHQ-9 ≥ 10) and 3% (n = 3/96) probable post-traumatic stress disorder (PC-PTSD-5 ≥ 4). The results compare with distress levels in the second pandemic wave: 31%, 24%, 15% and 3%, respectively. Multivariate analysis showed that patients who had investigations cancelled (OR 9.22, 95% CI 1.09-77.85; p = 0.041) or felt that the pandemic would affect their mental health (OR 3.82, 95% CI 1.96-7.44; p < 0.001) had increased risk of anxiety. Similarly, concern that the pandemic would affect their cancer treatment (OR 4.59, 95% CI 1.03-20.56; p = 0.046) or would affect their mental health (OR 3.90, 95% CI 1.38-11.03; p = 0.010) were found independent predictors of poor wellbeing.
Conclusions
The psychological distress experienced by patients, particularly anxiety, remained persistently high during the third wave of the COVID-19 pandemic. These updated results align with our initial findings, emphasizing the critical importance of continuing cancer treatment amidst the ongoing humanitarian emergency. It is crucial for healthcare services to prioritize ongoing psychological support for cancer patients, with a particular focus on those who are more vulnerable.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Servier.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1857P - Psychological distress in Georgian cancer patients undergoing chemotherapy: Before and after the COVID-19 pandemic
Presenter: Mariam Abuladze
Session: Poster session 05
1858P - Discrepancies between psychological stress and emotional care in cancer patients revealed in a social listening analysis
Presenter: Dalyong Kim
Session: Poster session 05
1859P - Digital goal management training as treatment for cognitive impairment in cervical cancer survivors: A feasibility study
Presenter: Elisabeth Areklett
Session: Poster session 05
1860P - Objective and subjective neurocognitive functioning (NCF) in advanced cancer survivors treated with immune checkpoint blockade (ICB)
Presenter: Nathalie Vanlaer
Session: Poster session 05
1861P - A randomized controlled trial on the efficacy and safety of the Untire app for moderate-to-severe cancer-related fatigue in German patients
Presenter: Simon Spahrkäs
Session: Poster session 05
1862P - Measuring the prevalence of fatigue in children with cancer: Evidence from Egypt
Presenter: Nourhan Abdalkader
Session: Poster session 05
1863P - Compassion fatigue among the staff involved in medical carcinology services
Presenter: Nouha Abidi
Session: Poster session 05
1864P - To what extent do nulliparous, female adolescents and young adults diagnosed with cancer have children after cancer treatment?
Presenter: Line Bentsen
Session: Poster session 05
1865P - Women with elderly early-stage breast cancer with type A personality may have decreased self-esteem after chemotherapy: A pilot study (POSEIDON Study)
Presenter: Ozgur Tanriverdi
Session: Poster session 05
1866P - Unmasking the extent of hidden sexual distress in young breast cancer survivors
Presenter: Zeineb Naimi
Session: Poster session 05